Provided by Tiger Trade Technology Pte. Ltd.

COMPASS Pathways plc

8.09
-0.1700-2.06%
Volume:2.01M
Turnover:16.46M
Market Cap:776.78M
PE:-2.96
High:8.40
Open:8.23
Low:8.03
Close:8.26
52wk High:8.90
52wk Low:2.25
Shares:96.02M
Float Shares:58.41M
Volume Ratio:0.43
T/O Rate:3.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7367
EPS(LYR):-2.2987
ROE:-205.81%
ROA:-38.43%
PB:20.66
PE(LYR):-3.52

Loading ...

Compass Pathways Shares Reverse Premarket Course; Last Down 4.4%

THOMSON REUTERS
·
Feb 19

Shares of Compass Pathways up 2.6% Premarket After Co Announces $150 Mln Equity Raise

THOMSON REUTERS
·
Feb 19

BUZZ-Compass Pathways climbs premarket after $150 mln equity raise

Reuters
·
Feb 19

Compass Pathways Prices $150 Million Public Offering

MT Newswires Live
·
Feb 19

BRIEF-Compass Pathways Announces Pricing Of $150 Million Public Offering

Reuters
·
Feb 19

Compass Pathways Plc - Prices Public Offering of 17.5 Mln Ads at $8.00 per Ads

THOMSON REUTERS
·
Feb 19

Compass Pathways Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Feb 19

Compass Pathways Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Feb 19

European Equities Traded in the US as American Depositary Receipts Higher Wednesday

MT Newswires Live
·
Feb 19

BUZZ-Compass Pathways extends rally after psychedelic depression treatment's late-stage study win

Reuters
·
Feb 18

Compass Pathways announces $150M American Depositary Shares offering

TIPRANKS
·
Feb 18

Compass Pathways Launches Proposed $150.0 Million Public Offering

THOMSON REUTERS
·
Feb 18

Top Midday Gainers

MT Newswires Live
·
Feb 18

Compass Pathways Plc : TD Cowen Raises Target Price to $29 From $23

THOMSON REUTERS
·
Feb 17

Robust Phase 3 Efficacy and Clean Safety Profile Drive Buy Rating on COMPASS Pathways’ CMPS

TIPRANKS
·
Feb 17

BUZZ-U.S. STOCKS ON THE MOVE-Ormat Technologies, Accenture, Kinsale Capital

Reuters
·
Feb 17

COMPASS Pathways Triumph In Hard To Treat Depression Ignites Investor Frenzy

Benzinga_recent_news
·
Feb 17

Analysts Conflicted on These Healthcare Names: Sensus Healthcare (SRTS), NeoGenomics (NEO) and COMPASS Pathways (CMPS)

TIPRANKS
·
Feb 17

Top Premarket Gainers

MT Newswires Live
·
Feb 17

Compass' psychedelic-based depression treatment scores second late-stage study win

Reuters
·
Feb 17